BAC
Bank of America Corporation
BAC has the edge over HBNC overall, supported by stronger fundamentals and stronger valuation.
HBNC
Horizon Bancorp, Inc.
HBNC's outlook is improving, though it still trails on the overall score.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
HBNC Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| N/A | |
| N/A |
HBNC's profitability is currently strong. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like HBNC.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over HBNC in the historical PE scenario, which offers more potential upside but is not a forecast.
HBNC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.8x | $13.59 | -36% |
| Forward | 9.6x | $21.19 | — |
| Fair | 10x | $20.01 | -5.6% |
| Current | 11x | $21.19 | — |
| Expensive | 19x | $38.49 | +82% |
Historical ranges are pointers, not guarantees.
HBNC's PE is in its fair range at 11x. If earnings grow as analysts expect, today's price would be 9.6x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
HBNC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for HBNC, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
HBNC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus HBNC up 326%.
HBNC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.20 | +10% |
| Q2 2025 | $1.17 | +172% |
| Q1 2025 | $1.02 | +89% |
| Q4 2024 | $0.80 | +25% |
| Q3 2024 | $0.47 | -72% |
| Q2 2024 | $0.43 | -77% |
| Q1 2024 | $0.54 | -73% |
| Q4 2023 | $0.64 | -70% |
| Q3 2023 | $1.70 | -21% |
HBNC earned $2.00 per share over the past year, about four times what it earned the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
HBNC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus up 16% for HBNC.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
HBNC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $75.5M | +14% |
| Q1 2026 | $73.5M | +6.9% |
| Q4 2025 | $74.9M | +210% |
| Q2 2025 | $66.3M | +19% |
| Q1 2025 | $68.8M | +29% |
| Q4 2024 | $24.2M | +11% |
| Q3 2024 | $58.4M | +8.3% |
| Q2 2024 | $55.8M | -2.4% |
HBNC's revenue has grown year over year for eight quarters in a row: $77M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 44% | N/A |
| Q2 2026 | 41% | +3.9 points |
| Q1 2026 | 44% | +3.2 points |
| Q4 2025 | 44% | +134 points |
| Q2 2025 | 37% | +8.4 points |
| Q1 2025 | 41% | +12 points |
| Q4 2024 | -91% | -4.5 points |
| Q3 2024 | 31% | -1.4 points |
HBNC has the edge over BAC on profitability, with a higher operating margin.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the stronger cash trend. Its trailing FCF is up 119% versus its history, compared with HBNC at up 52%.
HBNC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $31.3M | +73% |
| Q1 2026 | $20.7M | +47% |
| Q4 2025 | $32.6M | +$82.8M |
| Q2 2025 | $18.1M | +20% |
| Q1 2025 | $14.1M | +163% |
| Q4 2024 | -$50.2M | -468% |
| Q3 2024 | $31M | +8.1% |
| Q2 2024 | $15.1M | +7.1% |
HBNC's free cash flow was $111M over the past year, about nine times what it generated the year before. Free cash flow isn't a meaningful measure for financial services companies like HBNC.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over HBNC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
HBNC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +53.7K shares |
| 1 year | +17% | +7.3M shares |
| 3 years | +17% | +7.6M shares |
| 5 years | +16% | +7.2M shares |
| Available history | +14% | +6.3M shares |
HBNC has 51M diluted shares, up 17% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
HBNC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.5x | Net Cash |
| Q2 2025 | -2.4x | Net Cash |
| Q1 2025 | -3.4x | Net Cash |
| Q4 2024 | 24.9x | High |
| Q3 2024 | -5.7x | Net Cash |
| Q2 2024 | -3.6x | Net Cash |
| Q1 2024 | -6.0x | Net Cash |
| Q4 2023 | 16.6x | High |
HBNC has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
HBNC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.5 | Neutral |
| Stochastic | 76.2 | Neutral |
HBNC's weekly RSI is 67 (neutral) and its Stochastic is 76 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
HBNC PE vs Financial Services Sector
| Metric | HBNC | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 13x | 19% below |
| PE % | 60 | 63 | 3 pts below |
HBNC has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
HBNC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.1 | 5.6% above |
| 20 week MA | $20.0 | 6% above |
| 50 week MA | $18.7 | 14% above |
| 100 week MA | $17.2 | 23% above |
| 200 week MA | $15.0 | 41% above |
HBNC has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
HBNC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.0 | $15.6 | -18% |
| 2021 | $15.6 | $20.7 | +33% |
| 2022 | $20.7 | $15.2 | -26% |
| 2023 | $15.2 | $14.3 | -6% |
| 2024 | $14.3 | $16.1 | +12% |
| 2025 | $16.1 | $17.5 | +8.5% |
| 2026 YTD | $17.5 | $21.2 | +21% |
HBNC has the edge over BAC on returns for 2026, with the stronger performance.